These data suggest that autocrine PGE2 enhances neuroblastoma cell viability via a mechanism involving cAMP-mediated β-catenin stabilization, and suggest that this pathway is of relevance to high-risk neuroblastoma without MYCN amplification. This evidence concerns the gene MYCN and neuroblastoma.